Michael Mulroy

Michael Mulroy

Net worth: 322 439 $ as of 2026-07-30

60 year
Health Technology
Consumer Services
Finance

Profile

Michael H.
Mulroy
is Chairman at Lineage Cell Therapeutics, Inc. since 2024.
Director at Magtrol, Inc. since 2011.
Trustee at The Pegasus School.
President at Mulroy Advisors LLC since 2014.
Former President, Chief Executive Officer & Director at Asterias Biotherapeutics, Inc. from 2017 to 2019.
Independent Director at Comarco, Inc. from 2011 to 2014.
Director at AgeX Therapeutics, Inc. from 2014 to 2019.
Investment Banker at Citigroup, Inc. Secretary, EVP-Strategic Affairs & General Counsel at Questcor Pharmaceuticals, Inc. in 2014.
Executive VP-Strategic Affairs & General Counsel at Keenova Therapeutics Plc in 2014.
Partner at Stradling, Yocca Carlson & Rauth PC from 2004 to 2011.
Investment Banker at Merrill Lynch & Co., Inc. from 2003 to 2011.
Education includes graduate degree from the University of California, Los Angeles and undergraduate degree from The University of Chicago.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-30 298,555 ( 0.12% ) 322 439 $ 2026-07-30

Michael Mulroy active positions

CompaniesPositionStart
LINEAGE CELL THERAPEUTICS, INC. Chairman 2024-04-26
Director/Board Member 2011-01-10
President 2014-08-31
Director/Board Member -

Former positions of Michael Mulroy

CompaniesPositionEnd
AGEX THERAPEUTICS, INC. Director/Board Member 2019-07-29
ASTERIAS BIOTHERAPEUTICS INC Chief Executive Officer 2019-03-07
MALLINCKRODT PLC General Counsel 2014-08-31
COMARCO, INC. Director/Board Member 2014-08-24
QUESTCOR PHARMACEUTICALS INC Director of Finance/CFO 2014-02-16
See the detail of Michael Mulroy's experience

Training of Michael Mulroy

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

97

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Communications

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Commercial Services

Electronic Technology

Consumer Services

Consumer Services

Consumer Services

Finance

Commercial Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Michael Mulroy